Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment. [electronic resource]
- Journal of inherited metabolic disease Feb 2007
- 79-87 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1573-2665
10.1007/s10545-006-0473-y doi
1-Deoxynojirimycin--analogs & derivatives Animals Aorta--drug effects Disease Models, Animal Enzyme Inhibitors--therapeutic use Fabry Disease--drug therapy Female Humans Male Mice Mice, Inbred C57BL Mice, Knockout Microscopy, Electron Phenotype alpha-Galactosidase--genetics